StonvexLoading…
StonvexStonvexStonvexCore line items from FTHM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $420.48M | $335.18M | $345.23M | $412.96M |
Operating Income | $-15.58M | $-23.46M | $-23.25M | $-26.78M |
Net Income | $-20.31M | $-21.58M | $-23.98M | $-27.63M |
EPS (Diluted) | $-0.72 | $-1.07 | $-1.47 | $-1.73 |
Total Assets | $78.04M | $75.40M | $79.26M | $80.19M |
Total Liabilities | $40.60M | $30.72M | $24.02M | $18.17M |
Cash & Equivalents | $5.77M | $7.13M | $7.40M | $8.32M |
Free Cash Flow OCF − CapEx | $-20.66M | $-4.74M | $-10.59M | $-7.53M |
Shares Outstanding | 32.72M | 22.73M | 20.67M | 17.47M |